Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CIR Panel’s ‘Ethereal’ Role In Cosmetics Regulation Not Clarified By MoCRA

Mar 16 2023

• By Lauren Nardella

Related Content

FDA Balks At CIR Public-Private Partnership In FY 2017 Budget Request

Feb 15 2016

PCPC Hatching Proposal For CIR Role In FDA Ingredient Review

Mar 08 2017

US House Cosmetics Hearing: Preemption, FDA Ingredient Review Could Be Regulatory Reform Snags

Dec 05 2019

CIR Expert Panel Hastens Review Of Propolis Extract; Other Highlights From 164th Meeting

Mar 16 2023

Additional Topics

United States Legislation Cosmetic Ingredients Safety Cosmetics Consumer

More from Legislation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window